Clin2
NCT07421947Possibly a fitNot yet recruiting

Testing if a stool transplant helps diabetes and heart disease

Coronary Artery DiseaseType 2 Diabetes Mellitus (T2DM)

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This pilot study tests whether a fecal microbiota transplant (putting healthy donor stool into the colon) can improve health in people with type 2 diabetes and stable coronary artery disease. It will help researchers see if changing gut bacteria can help manage both conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 to 75 years old.
  • You have been diagnosed with type 2 diabetes.
  • You have stable coronary artery disease (narrowing in the heart's blood vessels that is not getting worse).
  • Your blood counts and clotting tests are within safe levels before the procedure.
  • You are willing to have a colonoscopy to receive the transplant.
  • You are not pregnant, breastfeeding, or planning to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07733232Not yet recruiting· Phase 4
Fecal transplant study for type 2 diabetes and Hashimoto's thyroiditis

This trial tests if a fecal microbiota transplant can help people with both type 2 diabetes and Hashimoto's thyroiditis. It aims to see if changing gut bacteria can improve blood sugar and thyroid health.

NCT04706611Recruiting
Stool transplant to treat gut and immune-related conditions

This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.

Guangzhou, Guangdong
NCT04014413Recruiting
Fecal transplant for gut and immune-related conditions

This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.

Hong Kong, Shatin
NCT06340828Not yet recruiting
Fecal transplant for diabetic stomach and bowel problems

This trial tests whether a treatment called washed microbiota transplantation (putting healthy bacteria into your gut) can help with stomach and bowel problems caused by type 2 diabetes. It aims to see if it's safe and if it improves symptoms.

Nanjing, Jiangsu
NCT06192693Recruiting· Phase 3
Fecal transplant to improve diabetes after weight loss surgery

This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.

Paris
NCT05664113Recruiting· Phase 1
Fecal transplant for gut problems after stem cell transplant

This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.

Memphis, Tennessee

Hear when a new Coronary artery disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.